Use of Irreversible Electroporation in Pancreatic Cancer Patients: A Multi-Center Experience

Background: Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival rate of 10%. Irreversible electroporation (IRE), a non-thermal ablative technique, may improve outcomes in locally advanced (LAPC) and borderline resectable pancreatic cancer (BRPC). This multi-center re...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Bart Hendrikx, Eline-Alice Brys, Alexandra Dili, Thomas Apers, Vera Hartman, Martin Brichard, Filip Gryspeerdt, Claude Bertrand, Geert Roeyen, Frederik Berrevoet
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-10-01
Edice:	Current Oncology
Témata:	pancreatic cancer irreversible electroporation margin accentuation tumor ablation outcomes
On-line přístup:	https://www.mdpi.com/1718-7729/32/10/574
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!